News for Catalyst Biosciences, Inc. (CBIO)

News for Catalyst Biosciences, Inc.
Date Headline
May 24, 2017 10:03 AM Catalyst Biosciences, Inc. :CBIO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
May 11, 2017 08:28 AM Catalyst Biosciences reports 1Q loss
May 11, 2017 08:01 AM Catalyst Biosciences Reports First Quarter 2017 Financial Results and Provides Corporate Update
May 03, 2017 09:30 AM Zacks.com featured highlights: PTC Therapeutics, Catalyst Biosciences, U.S. Silica Holdings, DXC Technology and Patterson-UTI Energy
Apr 12, 2017 04:01 PM Catalyst Biosciences Announces Closing of a $20.7 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
Apr 11, 2017 08:01 AM Key Milestone Reached in Catalyst’s Subcutaneous Factor IX Program
Apr 07, 2017 11:30 AM Catalyst Biosciences Sinks After Pricing Secondary Offering
Apr 07, 2017 08:30 AM Catalyst Biosciences Announces Pricing of $18 Million Underwritten Public Offering
Mar 30, 2017 05:00 PM Catalyst Biosciences Announces Emergence from Key Patent Opposition Period Supporting Marzeptacog Alfa (activated), Catalyst’s Lead Clinical Program
Mar 30, 2017 09:30 AM Today's Research Reports on Biotech Stocks to Watch: Catalyst Biosciences and Pernix Therapeutics